Stay updated on Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page.

Latest updates to the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page
- Check4 days agoChange DetectedThe page shows Revision: v3.6.4, replacing Revision: v3.6.3, indicating a minor platform update. It does not alter the study details or data presented on the page.SummaryDifference0.0%

- Check11 days agoChange DetectedThe page now lists 'Multiple myeloma' as a topic and adds 'MedlinePlus Genetics' as a related topic under related topics.SummaryDifference0.1%

- Check19 days agoChange DetectedMultiple myeloma is added as a condition keyword and MedlinePlus Genetics is added as a related topic, enriching the study's metadata and linking to patient education resources.SummaryDifference0.1%

- Check26 days agoChange DetectedA new page revision tag v3.6.3 was added, signaling an administrative update to the page. Some non-critical topics (Multiple myeloma, related topics, MedlinePlus Genetics) were removed from the listing.SummaryDifference0.1%

- Check40 days agoChange DetectedA new 'No longer looking for participants' banner indicates recruitment has closed for the study. Additional navigation/help items were added (How to Read a Study Record, Common Questions, How to Join a Study), a formatting adjustment from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision tag was updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check47 days agoChange DetectedThe revision tag on the page was updated to v3.5.5, replacing the previous v3.5.4. This reflects a new version of the document rather than changes to the study information.SummaryDifference0.0%

Stay in the know with updates to Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page.